Revenue
0 Unit12
2018-12-31 · Unit12
Fundies. English
REPLIMUNE GROUP, INC.
EDGAR45 filing records in this dataset, filed from 2018-06-22 to 2026-10-28. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating cash flow
-6.1 million Unit12
2018-12-31 · Unit12
Free cash flow
-6.74 million Unit12
2018-12-31 · Unit12
- Cash and cash equivalents
- 308 million USD Source
Exact value
307833000 USD
- Long-term debt including current maturities
- 44.4 million USD Source
Exact value
44434000 USD
- Shares outstanding
- 94.8 million shares Source
Exact value
94805154 shares
Reported share-count change
20.92% · 16.4 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-28.
Financial data available through: 2026-03-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 6 of 11 periods available· newest 2026-03-31
- Net income: 6 of 11 periods available· newest 2026-03-31
- Operating cash flow: 6 of 11 periods available· newest 2026-03-31
- Capital expenditure: 3 of 11 periods available· newest 2023-03-31
- Total assets: 6 of 11 periods available· newest 2026-03-31
- Total liabilities: 6 of 11 periods available· newest 2026-03-31
- Current assets: 6 of 11 periods available· newest 2026-03-31
- Current liabilities: 6 of 11 periods available· newest 2026-03-31
- Cash and cash equivalents: 6 of 11 periods available· newest 2026-03-31
- Long-term debt including current maturities: 2 of 11 periods available· newest 2023-03-31
- Shares outstanding: 6 of 11 periods available· newest 2026-03-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 66.6 millionPrior period
−USD 247.3 million
–
Current period
−USD 313.9 million
–
Exact inputs and evidence
-313900000 − -247300000 = -66600000 USD
-247300000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-313900000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 88.09 millionPrior period
−USD 192.25 million
–
Current period
−USD 280.34 million
–
Exact inputs and evidence
-280344000 − -192250000 = -88094000 USD
-192250000 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-280344000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-04-01 – 2021-03-31 | −USD 80.9 million Exact valueExact value: -80900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 61.39 million Exact valueExact value: -61389000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.39 million Exact valueExact value: 2392000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.78 million Calculation and evidence-61389000 − 2392000 USD Exact free cash flow: -63781000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-04-01 – 2022-03-31 | −USD 118 million Exact valueExact value: -118000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.18 million Exact valueExact value: -82180000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.34 million Exact valueExact value: 2336000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 84.52 million Calculation and evidence-82180000 − 2336000 USD Exact free cash flow: -84516000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-04-01 – 2023-03-31 | −USD 174.3 million Exact valueExact value: -174300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 128.05 million Exact valueExact value: -128050000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.27 million Exact valueExact value: 2270000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 130.32 million Calculation and evidence-128050000 − 2270000 USD Exact free cash flow: -130320000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-04-01 – 2024-03-31 | −USD 215.8 million Exact valueExact value: -215800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 185.47 million Exact valueExact value: -185467000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-04-01 – 2025-03-31 | −USD 247.3 million Exact valueExact value: -247300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 192.25 million Exact valueExact value: -192250000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-04-01 – 2026-03-31 | −USD 313.9 million Exact valueExact value: -313900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 280.34 million Exact valueExact value: -280344000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
45 filings · 2,261 latest values · 2,261 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001737953, 1737953, REPL, edgar:1737953
Also known as REPLIMUNE GROUP, INC., Replimune Group, Inc.